BioNTech SE (NASDAQ: BNTX) reported Q3 EPS of EUR0.81, EUR2.36 better than the analyst estimate of (EUR1.55). Revenue for the quarter came in at EUR1.24 billion versus the consensus estimate of EUR565.56 million.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.